Investing Profile

Asish Xavier

InvestorVC

Vice President, Venture Investments at Johnson & Johnson Innovation - JJDC, Inc

jnjinnovation.com/team/asish-...South San Francisco, California
Photo of Asish Xavier, Investor at Johnson & Johnson Innovation

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
18
CompanyStageDateRound SizeTotal Raised
PhaseBio Pharmaceuticals
Series CMar 2015$40M
Series BJun 2012$23M
Series BJan 2010$25M
Venture RoundOct 2007$6.6M
$130M
Co-investors: Robert Ingram (Hatteras Venture Partners), Justin Klein (Vensana Capital), James Barrett
Aduro BioTech
Series CJun 2014$56M
$56M
ViaCyte
Series CJul 2013$11M
Series CJul 2007$25M
Venture RoundMay 2006$20M
$140M
Co-investors: Heath Lukatch (Red Tree Venture Capital), Adam Koppel (Bain Capital Life Sciences)
Protagonist Therapeutics
Series BJun 2013$14M
$54M
Co-investors: Julie Grant (Canaan Partners)
Aquinox Pharmaceuticals
Series CApr 2013$18M
Series BJun 2010$25M
$43M
Catalyst Biosciences
Post-IPO EquityApr 2013$5.1M
Post-IPO EquitySep 2012$13M
Post-IPO EquityDec 2008$40M
$94M
Co-investors: Ralph (Chris) Christoffersen (Morgenthaler Ventures), Nassim Usman (Morgenthaler Ventures)
Nevro
Series CMar 2013$48M
$48M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners)
Genocea Biosciences
Series COct 2012$30M
Series BJan 2011$35M
Series BDec 2009€17M
€29M
$65M
Co-investors: Philippe Peltier (Kurma Partners), Kevin Bitterman (Atlas Venture), Ling Wong (Highbury Group), Simeon J. George (SR One)